Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Impaired Renal Function: later-stage trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Impaired Renal Function: 1 US clinical trial tracked, none currently recruiting.

Impaired Renal Function is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is American Regent, running 1 of these trials.

Enrollment posture brief

Registry condition impaired-renal-function

OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Impaired Renal Function (thi…0%
Open-enrollment share among volume-matched conditions near Impaired Renal Function

Impaired Renal Function has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Impaired Renal Function on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Impaired Renal Function is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

American Regent 1 trials

Named interventions

Most-linked intervention names on Impaired Renal Function records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Iron Sucrose (Venofer) Drug
1 trials
Ferric Carboxymaltose (FCM) Drug
1 trials

US sites by state

Facility locations filed on Impaired Renal Function trials. A trial with sites in several states counts in each.

Pennsylvania 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Impaired Renal Function page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Impaired Renal Function trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • American Regent sponsors the most Impaired Renal Function trials on record, review their full trial history before evaluating a specific study. See American Regent's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Impaired Renal Function condition card totals 1 registered trials; most-linked intervention Iron Sucrose (Venofer); top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.